Tracking the emergence of azithromycin resistance in multiple genotypes of typhoidal Salmonella

Sajib, M. S. I. , Tanmoy, A. M., Hooda, Y., Rahman, H., Andrews, J. R., Garrett, D. O., Endtz, H. P., Saha, S. K. and Saha, S. (2021) Tracking the emergence of azithromycin resistance in multiple genotypes of typhoidal Salmonella. mBio, 12(1), e03481-20. (doi: 10.1128/mbio.03481-20) (PMID:33593966)

Abstract

The rising prevalence of antimicrobial resistance in Salmonella enterica serovars Typhi and Paratyphi A, causative agents of typhoid and paratyphoid, have led to fears of untreatable infections. Of specific concern is the emerging resistance against azithromycin, the only remaining oral drug to treat extensively drug resistant (XDR) typhoid. Since the first report of azithromycin resistance from Bangladesh in 2019, cases have been reported from Nepal, India, and Pakistan. The genetic basis of this resistance is a single point mutation in the efflux pump AcrB (R717Q/L). Here, we report 38 additional cases of azithromycin-resistant (AzmR) Salmonella Typhi and Paratyphi A isolated in Bangladesh between 2016 and 2018. Using genomic analysis of 56 AzmR isolates from South Asia with AcrB-R717Q/L, we confirm that this mutation has spontaneously emerged in different Salmonella Typhi and Paratyphi A genotypes. The largest cluster of AzmR Typhi belonged to genotype 4.3.1.1; Bayesian analysis predicts the mutation to have emerged sometime in 2010. A travel-related Typhi isolate with AcrB-R717Q belonging to 4.3.1.1 was isolated in the United Kingdom, increasing fears of global spread. For real-time detection of AcrB-R717Q/L, we developed an extraction-free, rapid, and low-cost mismatch amplification mutation assay (MAMA). Validation of MAMA using 113 AzmR and non-AzmR isolates yielded >98% specificity and sensitivity versus phenotypic and whole-genome sequencing assays currently used for azithromycin resistance detection. With increasing azithromycin use, AcrB-R717Q/L is likely to be acquired by XDR strains. The proposed tool for active detection and surveillance of this mutation may detect pan-oral drug resistance early, giving us a window to intervene.

• Item Type: Articles
• Status: Published
• Refereed: Yes
• Glasgow Author(s) Enlighten ID: Sajib, Mohammad Saiful Islam
• Authors: Sajib, M. S. I., Tanmoy, A. M., Hooda, Y., Rahman, H., Andrews, J. R., Garrett, D. O., Endtz, H. P., Saha, S. K., and Saha, S.
• College/School: College of Medical Veterinary and Life Sciences
• Journal Name: mBio
• Publisher: American Society for Microbiology
• ISSN: 2150-7511
• ISSN (Online): 2150-7511
• Published Online: 16 February 2021
• Copyright Holders: Copyright © 2021 Sajib et al.
• First Published: First published in mBio 12(1) e03481-20
• Publisher Policy: Reproduced under a Creative Commons License